Gene expression profiling of 1200 pancreatic ductal adenocarcinoma reveals novel subtypes

BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) is the fourth leading cause of cancer related death in the world with a five-year survival rate of less than 5%. Not all PDAC are the same, because there exist intra-tumoral heterogeneity between PDAC, which poses a great challenge to personalized...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Lan, Zhao, Hongya, Yan, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5975421/
https://www.ncbi.nlm.nih.gov/pubmed/29843660
http://dx.doi.org/10.1186/s12885-018-4546-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5975421/
https://www.ncbi.nlm.nih.gov/pubmed/29843660
http://dx.doi.org/10.1186/s12885-018-4546-8

Ejemplares similares